PHOTO
Doha, Qatar – Sidra Medicine, a Qatar Foundation entity, has appointed Dr. Barbro Fridén as its Chief Executive Officer.
Dr. Fridén has extensive experience in both the public and private healthcare sectors in Sweden and the Middle East.
Prior to joining Sidra Medicine, Dr. Fridén was the CEO of Sheikh Khalifa Medical City in Ajman and before that, the CEO of Sahlgrenska University Hospital, Scandinavia’s largest teaching hospital. Dr. Fridén was previously the Hospital Director of the Children’s Hospital at Karolinska University Hospital in Sweden.
Mr. Mohammed Khalid Al Mana, Managing Director and Member of the Board of Governors at Sidra Medicine said: “We are delighted to have Dr. Barbro Fridén join us at Sidra Medicine. Her leadership experience in obstetrics and gynecology and experience in having led women’s and children’s hospitals in Sweden, will be a tremendous asset to our patient care model as we embark on strengthening and expanding our services in Qatar. We look forward to Dr. Fridén’s stewardship over the next chapter of our journey towards achieving our overall vision of becoming a beacon of learning, discovery and exceptional care.”
Dr. Barbro Fridén said: “I am excited to be joining Sidra Medicine during this dynamic phase as the healthcare organization is poised for new opportunities for growth. Together with our diverse multidisciplinary teams, I look forward to building on Sidra Medicine’s legacy of providing quality care and a personalized patient experience with excellent medical outcomes built on a strong research foundation of precision medicine.”
Dr. Fridén is well recognized within her field having won “Leader of the Year”, a national award in Sweden in 2015 as well as “Influencer of the Year” in 2014, a life science business national award.
Dr. Fridén sits on the board on a variety of government and commercial boards related to healthcare including a leading medtech company and Sophiahemmet, a non-profit healthcare provider under royal stewardship that conducts education, healthcare and research.
Dr Fridén received her medical degree from Umeå University in Sweden, specializing in obstetrics and gynecology with a subspecialty in reproductive medicine and IVF. She was also a visiting research fellow in reproductive medicine at the University of California. She holds a PhD in Medicine from Gothenburg University.
- Ends -
For media enquiries and interviews contact: pr@sidra.org
About Sidra Medicine
Sidra Medicine provides specialized healthcare to women, children, and young people from Qatar and around the world. Established by Qatar Foundation for Education, Science and Community Development, Sidra Medicine embraces best practice medical education, innovative biomedical and clinical research and discovery, and exceptional patient and family focused care.
Sidra Medicine provides comprehensive specialist healthcare services for children and young people, as well as maternity and gynecology care for women. Some of its unique children’s specialist services include Cardiology, Neurology, Urology and Plastics & Craniofacial Reconstruction. It is also currently the only specialist center in the country that treats and cares for pregnant women with fetal complications.
The ultramodern healthcare organization is a testament to Qatar’s pioneering spirit and sustained commitment to its human and social development.
To access Sidra Medicine services, and learn more about our contribution to global healthcare, education and research, please visit www.sidra.org.
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
